Well defined system and method for monitoring neurological disease onset and progress and onset of the effects of neuropharmacological drugs using the recency-primacy shift and overall free recall differences
Given free recall or recognition test results of normal and disease populations, the present innovation provides methods for determining how close a single test subject is to the profile of a diseased population. The methods use the total items remembered and a defined recency-primacy shift to determine how similar the test subject is to a disease population. The methods are well defined and do not involve any “tinkering”.
